Filing Flows › Materials › Innospec (IOSP)
Innospec (IOSP) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Nov 4, 2026 · Innospec (IOSP) Q3 2026 earnings results →
Q3 2026 Revenue up 7% year over year to $474M · 7¢ of every $1 of revenue kept as net profit · operating margin 8.8%
Innospec made $474M in Q3 2026 (+7% Y/Y). Operating margin 8.8%, net earnings $31.6M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 4, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $473.6M in Q3 2026, up 7% year over year and down 4% from the previous quarter.
Gross margin was 27.3%, up 0.9 points from Q3 2025. Operating profit was $41.7M, a 8.8% margin (up 7.5 points year over year). Of the extra revenue versus Q3 2025, 113% reached operating profit, above the 1% margin then. Operating expenses fell 21% while revenue rose 7%. Net earnings were $31.8M, up 147% year over year. The effective tax rate was 25.8%.
Operating cash flow was $17.4M (down 55% year over year), 55% of net earnings. Non-cash charges added back $9.6M of depreciation and amortization and $1.4M of share-based compensation. Working capital and other items used $25.2M. Capital expenditures of $15.8M left free cash flow of $1.6M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Nov 4, 2026 | $474M | +7% | 8.8% | $31.6M | $17.4M |
| Q2 2026 | 10-Q | Aug 5, 2026 | $491M | +12% | 8.1% | $31.2M | $7.2M |
| Q1 2026 | 10-Q | May 8, 2026 | $453M | +3% | 8.1% | $30.4M | $17.6M |
| Q4 2025 | 10-K | Feb 18, 2026 | $456M | -2% | 10.3% | $46.4M | $60.4M |
| Q3 2025 | 10-Q | Nov 5, 2025 | $442M | -0.3% | 1.3% | $12.9M | $39.1M |
| Q2 2025 | 10-Q | Aug 6, 2025 | $440M | +1% | 7.8% | $23.5M | $10.5M |
| Q1 2025 | 10-Q | May 9, 2025 | $441M | -12% | 9.6% | $32.8M | $28.3M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Innospec
When we use the terms “Innospec,” “the Corporation,” “the Company,” “Registrant,” “we,” “us” and “our,” we are referring to Innospec Inc. and its consolidated subsidiaries unless otherwise indicated or the context otherwise requires. Innospec develops, manufactures, blends, markets and supplies a wide range of specialty chemicals to customers in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Our Performance Chemicals business creates innovative technology-based solutions for the personal care, home care, agrochemical, construction, mining and other industrial markets. Our Fuel Specialties business specializes in manufacturing and supplying fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions.
In its own words, from its 10-K, filed Feb 18, 2026.
Innospec against its Chemicals & Allied Products peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +7% against the peers' median +8%. Operating margin: 8.8% against the peers' median 9.5%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| IOSP Innospec | Q3 2026 | $474M | +7% | 8.8% |
| OLN Olin | Q3 2026 | $1.7B | +2% | 3.4% |
| HUN Huntsman | Q3 2026 | $1.7B | +18% | 2.3% |
| Huntsman International LLC | Q2 2026 | $1.7B | +14% | 2.2% |
| CC Chemours | Q3 2026 | $1.5B | +3% | 14.4% |
| SOLS Solstice Advanced Materials | Q3 2026 | $1.0B | +8% | 10.7% |
| PRM Perimeter Group | Q3 2026 | $390M | +24% | 106.8% |
| ECVT Ecovyst | Q3 2026 | $309M | +51% | 9.5% |
| NGVT Ingevity | Q3 2026 | $305M | -8% | 22.0% |
Source: Innospec 10-Q on SEC EDGAR · CIK 1054905 · Chemicals & Allied Products
13F: who owns IOSP and who is buying
More on IOSP
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results